Humoral and Cellular Immune Response of Herpes Simplex (gD) Candidate Vaccines From 2 Different Cell Lines

Clinical trial NCT00698490 · COMPLETED

Trial details

NCT number: NCT00698490
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prophylaxis Herpes Simplex

Start date: 1995-08-01
Primary completion: 1997-01-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.